A gamma -2 Herpesvirus Nucleocytoplasmic Shuttle Protein Interacts with Importin alpha 1 and alpha 5*

Delyth J. GoodwinDagger and Adrian Whitehouse§

From the Molecular Medicine Unit, University of Leeds, St. James's University Hospital, Leeds LS9 7TF, United Kingdom

Received for publication, October 18, 2000, and in revised form, February 22, 2001

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Herpesvirus saimiri (HVS) is the prototype gamma -2 herpesvirus. This is an increasing important subfamily of herpesviruses due to the identification of the first human gamma -2 herpesvirus, Kaposi's sarcoma-associated herpesvirus. The HVS open reading frame (ORF) 57 protein is a multifunctional trans-regulatory protein homologous to genes identified in all classes of herpesviruses. Recent analysis has demonstrated that ORF 57 has the ability to bind viral RNA and to shuttle between the nucleus and cytoplasm, and is required for efficient nuclear export of viral transcripts. Here we have investigated the nucleocytoplasmic shuttling mechanism utilized by the ORF 57 protein. The yeast two-hybrid system was employed to identify interacting cellular proteins using ORF 57 as bait. We demonstrate that ORF 57 interacts with importin alpha  isoforms 1 and 5. In addition, the binding of ORF 57 to importin alpha  was mediated by the importin alpha  hydrophobic internal armadillo repeats. An ORF 57 amino-terminal arginine-rich sequence, which functions as a nuclear localization sequence, was also required for this interaction. Furthermore, the ORF 57 protein is responsible for the redistribution of importin alpha  into the nucleoli. These results identify novel cellular interactions essential for the functioning of this important herpesvirus regulatory protein.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

A number of viruses including herpes, adenovirus, influenza, and retroviruses replicate in the host cell nucleus. In order to complete their virus replication cycle, they have devised a number of mechanisms to transport viral nucleic acids into and out of the nucleus. In particular, a variety of viruses encode nucleocytoplasmic shuttle proteins, which specifically mediate the nuclear export of viral RNA. Such virally encoded proteins include human immunodeficiency virus type 1 (HIV-1)1 Rev, herpes simplex virus type 1 (HSV-1) ICP27, influenza virus NEP, adenovirus E4orf6, and the herpesvirus saimiri (HVS) ORF 57 protein (1-6). Herpesvirus saimiri (HVS) is the prototype gamma -2 herpesvirus, or rhadinovirus (7), an increasingly important family of viruses due to the recent identification of the first human gamma -2 herpesvirus, Kaposi's sarcoma-associated herpesvirus (8). Gene expression during HVS lytic replication is sequentially regulated and occurs in three main temporal phases: immediate-early, delayed-early, and late. The two major HVS transcriptional regulating proteins are encoded by the open reading frames (ORFs) 50 and 57 (9-12).

ORF 57 is a 52-kDa multifunctional trans-regulatory protein homologous to genes identified in all classes of herpesviruses. Transactivation of late viral genes by ORF 57 occurs independently of target gene promoter sequences and appears to be mediated at a post-transcriptional level (11). In addition to its transactivation properties, ORF 57 is responsible for repression of viral gene expression, which correlates with the presence of introns within the target gene (11-12). ORF 57 also redistributes both U2 and SC-35 splicing factors during an HVS infection into intense distinct nuclear aggregations (13). Recent analysis has demonstrated that the ORF 57 protein has the ability to bind viral RNA and shuttle between the nucleus and cytoplasm, and is required for efficient cytoplasmic accumulation of virus mRNA. This suggests that ORF 57 plays a pivotal role in mediating the nuclear export of viral transcripts (6).

An intriguing question regarding the functioning of virus-encoded nucleocytoplasmic shuttle proteins is the mechanism they utilize to be transported through the nuclear pore complex. Macromolecule trafficking into and out of the nucleus is mediated by soluble transport receptors (reviewed in Ref. 14). These receptors bind specific proteins or RNA cargoes and interact with nuclear pore proteins, which subsequently allow the translocation of the receptor cargo through the nuclear pore complex. Recently, CRM-1 (for chromosomal region maintenance 1) or exportin 1, a protein that shares homology with members of the importin-karyopherin nuclear transport pathway, has been identified as a nuclear export receptor for proteins, including HIV-1 Rev, carrying a leucine-rich NES in a process that also requires the GTP-bound form of Ran (15-16). Furthermore, CRM-1 has been shown to interact with nuclear pore complex proteins, namely the nucleoporins CAN/Nup214 and Nup88 (16), suggesting that CRM-1 is the bridging protein for the interactions of NES-containing proteins and the nuclear pore complex. However, it has recently been shown for the herpesviruses HSV-1 and Epstein-Barr virus that, although export of some viral RNAs require the CRM-1 pathway, a proportion of viral RNA export can be mediated by a CRM-1-independent pathway (17-18). This suggests that at least some herpesvirus nucleocytoplasmic shuttle proteins may function through a distinct, as yet unidentified, export mechanism.

In addition, it is tempting to speculate that the virally encoded nucleocytoplasmic shuttle proteins must interact with cellular nuclear import pathways. The most widely characterized transport pathway mediates the nuclear import of proteins that contain a classical nuclear localization signal (NLS) (reviewed in Ref. 14). These basic, generally lysine-rich NLS serve as recognition sites for an NLS receptor termed importin alpha  or karyopherin alpha  (19), which forms a heterodimeric complex with importin beta  or karyopherin beta . Importin beta  functions as a transport adapter molecule binding to the nuclear pore complex via a direct interaction with specific nucleoporins (20, 21). Once in the nucleus, binding of Ran-GTP to importin beta  causes dissociation of the import complex (22, 23). Once released from the cargo, importin subunits are then recycled to the cytoplasm. Importin beta  is recycled rapidly, whereas the export of importin alpha  is mediated by the nuclear export factor, CAS, which binds importin alpha  preferentially in the presence of Ran-GTP (24-26). In the cytoplasm the importin molecules are released by the action of RanBP1 and RanGAP1 (27-29), allowing participation in additional rounds of nuclear import.

In this report we have investigated the nucleocytoplasmic shuttling mechanism utilized by the HVS ORF 57 protein. The yeast two-hybrid system was employed to identify interacting cellular proteins using ORF 57 as bait. Here we show that ORF 57 interacts with importin alpha  isoforms 1 and 5. Confirmation of this interaction was provided by co-immunoprecipitation experiments from transfected and infected cells. In addition, the binding of ORF 57 to importin alpha  is mediated via the hydrophobic, internal, importin alpha  armadillo (arm) repeats. Moreover, an ORF 57 amino-terminal arginine-rich sequence, which functions as an NLS, is required for this interaction. Furthermore, the ORF 57 protein is responsible for the redistribution of importin alpha  into the nucleoli.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Yeast Two-hybrid Screen for ORF 57-interacting Proteins-- The GAL4-based yeast two-hybrid system screening technique (30) was employed to identify ORF 57-interacting proteins. The "bait" plasmid was constructed by PCR amplication of the ORF 57 coding region using forward and reverse primers. These oligonucleotides incorporated BamHI and PstI restriction sites for the convenient cloning of the PCR fragment into pGBT9 (CLONTECH), to derive the GAL4 DNA-binding domain fusion, pDBD57. A human kidney cDNA-GAL4 activation domain fusion library in the vector pACT2 (CLONTECH) was utilized to identify ORF 57-interacting proteins. The bait plasmid was transformed into the Saccharomyces cerevisiae strain HF7c (CLONTECH). Clones were selected on minimal synthetic dropout medium in the absence of tryptophan. Yeast clones harboring the bait plasmids were then sequentially transformed with the "prey" library. Positive clones, potentially harboring ORF 57-interacting species, were identified both by their ability to grow on media without tryptophan, leucine, and histidine and by the detection of beta -galactosidase activity. Plasmids were isolated from positive yeast clones, selecting for pACT2 cDNA library plasmids by transformation of the leucine auxotroph into Escherichia coli strain HB101. To confirm the specificity of the interactions, pACT-2 library plasmids were transformed into yeast strains harboring no plasmid, yeast containing pGBT9 vector only, yeast containing pLAM5 (a GAL4 human lamin C fusion), or pDBD57. Only those library plasmids demonstrating a requirement for the pDBD57 plasmid for induced expression of HIS3 or lacZ reporter genes were considered further and selected for DNA sequencing.

Plasmid Constructs-- The yeast two-hybrid importin alpha 1 and alpha 5 deletion series were produced by a PCR-based method using a series of forward and reverse primers. The oligonucleotides incorporated BamHI and XhoI restriction sites for the convenient cloning of the PCR products. Each fragment was inserted into the yeast two-hybrid expression vector, pACT2, in frame with the GAL4-AD, to derive the deletion series pADalpha 1Delta 1-6 and pADalpha 5Delta 1-5. The bacterial expression importin alpha 1 and alpha 5 deletion series were produced by cloning the alpha 1 and alpha 5 deletion PCR fragments into pGEX5T, to derive the GST fusion constructs, pGSTalpha 1Delta 1-4 and pGSTalpha 5Delta 1-5.

The yeast two-hybrid ORF 57 deletion series was produced by a PCR-based method using a series of forward and reverse primers. The oligonucleotides incorporated BamHI and PstI restriction sites for the convenient cloning of the PCR products. Each fragment was inserted into the yeast two-hybrid expression vector, pGBT9, in frame with the GAL4-DBD, to derive the deletion series pDBD57Delta 1-5. The ORF57-GFP and ORF 57 amino-terminal deletion series were again generated by PCR amplication, again using a series of forward and reverse primers. These oligonucleotides incorporated BamHI and PstI restriction sites to facilitate cloning of the PCR product into the eukaryotic expression vector, pcDNAGFP (Invitrogen), to yield p57GFP and p57NDelta 1-3GFP. To produce p57NLS-GFP, oligonucleotides encoding the putative ORF 57 NLS, nucleotides in bp 78580-78820 of the published sequence (7), were synthesized. These oligonucleotides incorporated BamHI and XhoI restriction sites, for convenient cloning. The oligonucleotides were annealed and ligated with pEGFP-C1 (CLONTECH) to create an in-frame carboxyl-terminal fusion of the NLS sequence and GFP. To produce p57NLSM1-4, containing alterations within the putative ORF 57 NLS, oligonucleotides that incorporated the alteration of arginines and lysine to alanine residues were synthesized encompassing nucleotides in bp 78677-78774 of the published sequence. These oligonucleotides incorporated BglII and PflMI restriction sites, for convenient cloning into pBKRSV57 (11), previously digested with BglII and PflMI, thereby replacing the wild type coding region with the site-directed mutated sequence.

The importin alpha 1-GFP and alpha 5-GFP constructs were generated by PCR amplication of the complete alpha 1 and alpha 5 cDNA sequences using forward and reverse primers. These oligonucleotides incorporated BamHI and XhoI restriction sites to facilitate cloning of the PCR products. Each fragment was inserted into the eukaryotic expression vector, pcDNAGFP (Invitrogen) to yield palpha 1-GFP and palpha 5-GFP, respectively. These constructs contained a carboxyl-terminal GFP fusion tag, which allowed direct visualization of the importin alpha -GFP proteins using fluorescence microscopy. To produce pSV40NLS-RFP, oligonucleotides encoding the SV40 NLS, PKKKRKV, were synthesized. These oligonucleotides incorporated XhoI and BamHI restriction sites, for convenient cloning. The oligonucleotides were annealed and ligated with pDsRed1-N1 (CLONTECH) to create an in-frame carboxyl-terminal fusion of the SV40 NLS and RFP. The sequences of all primers used in this report can be obtained directly from the authors.

Viruses, Cell Culture, and Transfections-- HVS (strain A11) was propagated in owl monkey kidney cells, which were maintained in Dulbecco's modified Eagle's medium (Life Technologies, Inc.) supplemented with 10% fetal calf serum. COS-7 cells were also maintained in Dulbecco's modified Eagle's medium supplemented with 10% fetal calf serum. Plasmids used in the transfections were prepared using Qiagen plasmid kits according to the manufacturer's directions. Transfections were performed using LipofectAMINE (Life Technologies, Inc.) as described by the manufacturer, using 2 µg of the appropriate DNAs.

Co-immunoprecipitation Assays-- COS-7 cells either remained untransfected, were transfected using 2 µg of the appropriate DNAs, or were infected with HVS at a multiplicity of infection of 1. After 48 h, cells were harvested and lysed with lysis buffer (0.3 M NaCl, 1% Triton X-100, 50 mM HEPES buffer, pH 8.0) containing protease inhibitors (leupeptin and phenylmethylsulfonyl fluoride). For each immunoprecipitation, 10 µl of the ORF 57 polyclonal (31) or GFP monoclonal antiserum (CLONTECH) were incubated with protein A-Sepharose beads (Amersham Pharmacia Biotech) for 16 h at 4 °C. The beads were then pelleted, washed, and incubated with each respective cell lysate for 16 h at 4 °C. The beads were then pelleted and washed, and precipitated polypeptides were resolved on a 12% SDS-polyacrylamide gel and analyzed by immunoblot analysis.

Immunoblot Analysis-- Polypeptides were resolved on a 12% SDS-polyacrylamide gel, then soaked for 10 min in transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol (v/v)). The proteins were transferred to nitrocellulose membranes by electroblotting for 3 h at 250 mA. After transfer, the membranes were soaked in PBS and blocked by preincubation with 2% (w/v) nonfat milk powder for 2 h at 37 °C. Membranes were incubated with a 1:400 dilution of the anti-importin alpha 1,alpha 5 polyclonal antisera or a 1:1000 dilution of anti-GFP (CLONTECH), washed with PBS, and then incubated for 1 h at 37 °C with a 1:1000 dilution of secondary immunoglobulin conjugated with horseradish peroxidase (Dako) in blocking buffer. After five washes with PBS, the nitrocellulose membranes were developed using ECL (Pierce).

GST Pull-down Assays-- The importin alpha -deletion series were expressed as GST fusion proteins in E. coli DH5alpha . A fresh overnight culture of transformed E. coli was diluted 1 in 20 with LB medium. After growth at 37 °C for 2 h, the culture was induced with 1 mM IPTG and grown at 37 °C for an additional 4 h. The cells were harvested and resuspended in 0.1 volume of lysis buffer (100 mM Tris-HCl, pH 8.0, 200 mM NaCl, 1% Triton X-100). Cells were sonicated and stored on ice for 30 min, and cellular debris pelleted. The recombinant protein was purified from crude lysates by incubation with glutathione-Sepharose 4B affinity beads. The protein-bound beads were then incubated with untransfected or appropriate transfected COS-7 cell lysates previously treated with lysis buffer for 16 h at 4 °C. The beads were then pelleted and washed, and precipitated polypeptides resolved on a 12% SDS-polyacrylamide gel. The proteins were then transferred to nitrocellulose membranes by electroblotting and probed as described previously.

Immunofluorescence Analysis-- Cells were fixed with 100% ice-cold methanol for 10 min. The cells were rinsed in PBS and blocked by preincubation with 1% (w/v) nonfat milk powder for 1 h at 37 °C. A 1:100 dilution of anti-ORF 57 polyclonal antiserum (31) or 1:50 dilution of B23 monoclonal antibody was layered over the cells and incubated for 1 h at 37 °C. Texas Red-conjugated immunoglobulin (Dako; 1:200 dilution) was added for 1 h at 37 °C. After each incubation step, cells were washed extensively with PBS. The immune fluorescence slides were examined using a Zeiss Axiovert 135TV inverted microscope with a Neofluar 40× oil immersion lens.

Northern Blot Analysis-- Northern blot analysis was performed as previously described (6). Total, nuclear, and cytoplasmic RNA was isolated from transfected cells and separated by electrophoresis on 1% denaturing formaldehyde-agarose gel. The RNA was transferred to Hybond-N membranes and hybridized with 32P-radiolabeled random-primed probes specific for gB and actin coding sequences.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Importin alpha 1 and alpha 5 Interact with HVS ORF 57-- To identify ORF 57-interacting cellular proteins, 1.5 × 106 independent cDNA clones of a human kidney cDNA library fused to the GAL4 activation domain were screened. 24 clones were identified that activated histidine and beta -galactosidase reporter gene expression in the presence of the ORF 57-DBD fusion protein. The specificity of the interaction was confirmed by transforming the putative ORF 57-interacting cellular clones into yeast strains harboring no plasmid, yeast containing pGBT9 vector only, yeast containing pLAM5 (a GAL4 human lamin C fusion), or pDBD57. Only those library plasmids demonstrating a requirement of pDBD57 for induced expression of histidine and beta -galactosidase reporter genes were considered further.

Clones that fulfilled all these criteria were sequenced and BLAST searched against the EMBL/GenBankTM data base. Analysis revealed that seven ORF 57-interacting clones corresponded to importin alpha 1/karyopherin alpha 2/Rch1 and that four clones corresponded to importin alpha 5/karyopherin alpha 1/hSRP1.

In Vitro Co-immunoprecipitation of ORF 57 and Importin alpha 1 and alpha 5-- To confirm whether the observed interaction of ORF 57 with importin alpha 1 or alpha 5 could also be observed in vitro, co-immunoprecipitation studies were performed. Control untransfected COS-7 cells were compared with cells transfected with pRSVORF57, a eukaryotic expression vector encoding the complete coding region of ORF 57 (11), or HVS-infected cells (multiplicity of infection of 1). After 24 h, the cells were harvested and cell lysates utilized in co-immunoprecipitation analysis using an anti-ORF 57 polyclonal antiserum. Polypeptides precipitated from untransfected, transfected, and infected cellular extracts were then resolved on SDS-PAGE and transferred to a nitrocellulose membrane. Immunoblot detection was performed using antiserum specific for importin alpha 1 or alpha 5. The results demonstrate that, in both ORF 57-transfected and HVS-infected cells, ORF 57 specifically interacts with both importin alpha 1 and alpha 5 (Fig. 1).


View larger version (108K):
[in this window]
[in a new window]
 
Fig. 1.   ORF 57 interacts with both importin alpha 1 and alpha 5. To determine whether ORF 57 interacts with importin alpha , co-immunoprecipitations were performed. Control total lysate (lane 1), untransfected (lane 2), p57-transfected (lane 3), and HVS-infected (lane 4) cell extracts were immunoprecipitated using ORF 57 antiserum. Bound proteins were resolved on a 12% SDS-PAGE gel and the presence of importin alpha 1 (a) and alpha 5 (b) were detected by Western blot analysis.

Importin alpha 1 and alpha 5 Interact with ORF 57 via Their Armadillo Repeats-- To map the domains within importin alpha 1 and alpha 5 required for their specific interaction with ORF 57, a series of importin alpha 1 and alpha 5 truncations were expressed as fusions with GAL4-AD (Fig. 2a). Competent yeast strain HF7c was co-transformed with pDBD57 and each importin truncation AD plasmid, and assessed for their ability to grow on selective medium. The results indicated that the ORF 57 binding region maps to amino acids 291-450 of importin alpha 1 and amino acids 253-459 of importin alpha 5, encompassing the central 5-8 arm repeats in both cases. Smaller deletions within these regions of either importin alpha  abolished the interaction, suggesting that all the 5-8 armadillo repeats are required for ORF 57 binding.


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 2.   ORF 57 interacts with arm 5-8 repeats of importin alpha . a, a series of importin alpha 1 and alpha 5 deletions were generated by PCR amplication and inserted into pACT2. Each deletion plasmid was co-transformed into HF7c with pDBD57 and assessed for the ability to grow on selective medium. Results of a positive interaction are indicated by +, whereas no interaction is indicated by -. b, i, control GST alone and the GST-importin alpha 1 and alpha 5 deletion series were expressed in E. coli and purified from crude lysate by incubation with glutathione-Sepharose 4B affinity beads; ii, protein extracts of p57GFP-transfected cells were incubated with each GST-importin alpha  fusion protein. Bound proteins were resolved on a 12% SDS-PAGE gel, and the presence of ORF 57-GFP was detected by Western blotting using anti-GFP antiserum.

To confirm these results in vitro, GST pull-down assays were performed. The importin alpha 1 and alpha 5 deletion series were expressed as GST fusion proteins. Protein extracts prepared from p57GFP-transfected cells were incubated with each GST-importin alpha  fusion protein bound to glutathione beads. To confirm the expression of ORF57-GFP in each experiment, fluorescence microscopy was utilized (data not shown). Bound proteins were then separated by SDS-PAGE, and the presence of ORF57-GFP was detected by Western blotting using a GFP monoclonal antibody (Fig. 2b). Results demonstrated that ORF 57 specifically bound to GST-importin alpha 1Delta 3 and GST-importin alpha 5Delta 5, corresponding to the respective arm 5-8 repeats. An ORF57-GFP tagged expression vector was utilized in this experiment due to the lack of reactivity of the ORF 57 polyclonal antiserum in Western blot analysis, as reported previously (31). A GFP alone control was also utilized in this experiment and was shown not to interact with any of the GST-importin alpha  fusion proteins (data not shown).

The ORF 57 Amino-terminal Arginine-rich Sequence Is Required for Importin alpha  Binding-- To delineate the domains within ORF 57 required for its specific interaction with importin alpha 1 and alpha 5, a series of ORF 57 deletions were expressed in yeast as fusions with GAL4-DBD (Fig. 3a). Competent yeast strain HF7c was co-transformed with either importin alpha 1-AD or importin alpha 5-AD and each of pDBD57Delta 1-6, and assessed for the ability to grow on selective medium. The results indicated that the amino terminus of ORF 57 is required for its interaction with importin alpha 1 and alpha 5. Further deletions identified a relatively arginine-rich region, encompassing bp 78580-78820 of the published sequence (7), required for the interaction with importin alpha 1 and alpha 5.


View larger version (26K):
[in this window]
[in a new window]
 
Fig. 3.   The ORF 57 amino terminus is required for importin alpha  binding. A series of ORF 57 deletions was generated by PCR amplication and inserted into pGBT9. Each deletion plasmid was co-transformed into HF7c with pADalpha 1Delta 3 and pADalpha 5Delta 5 and assessed for the ability to grow on selective medium. Results of a positive interaction are indicated by +, whereas no interaction is indicated by -.

To confirm whether the ORF 57 amino-terminal arginine-rich sequence was required for the interaction with importin alpha 1 and alpha 5, co-immunoprecipitation analysis was performed using an ORF 57 amino-terminal deletion series (Fig. 4). Control untransfected COS-7 cells were compared with cells transfected with the pORF57-GFP or p57NDelta 1-3. To confirm the expression of ORF 57-GFP and deletions in each experiment, fluorescence microscopy was utilized (data not shown). After 24 h, the cells were harvested and cell lysates utilized in co-immunoprecipitation analysis using the GFP antiserum. Polypeptides precipitated were resolved on SDS-PAGE and transferred to a nitrocellulose membranes, and immunoblot detection was performed using antiserum specific for importin alpha 1 or importin alpha 5. The results demonstrate that the amino-terminal arginine-rich sequence of ORF 57 is required for its interaction with importin alpha 1 and alpha 5 (Fig. 4).


View larger version (57K):
[in this window]
[in a new window]
 
Fig. 4.   The ORF 57 amino-terminal arginine-rich sequence is required for importin alpha  binding. a, an ORF 57 amino-terminal deletion series was generated by PCR amplication and inserted into pcDNAGFP. b, control or p57NDelta 1-3-transfected COS-7 cell extracts were immunoprecipitated using GFP-antiserum. Bound proteins were resolved on a 12% SDS-PAGE gel, and the presence of importins alpha  1 and alpha 5 was detected by Western blot analysis.

The ORF 57 Amino-terminal Arginine-rich Sequence Functions as an NLS-- To determine if the arginine-rich sequence functions as a NLS, the subcellular localization of the ORF 57 amino-terminal deletion series was analyzed. These constructs contained a carboxyl-terminal GFP fusion tag, allowing direct visualization. Transient p57NDelta 1-3 transfections were performed, and the resulting fluorescence pattern was subsequently evaluated. pcDNAGFP was used as a control and displayed, as expected, a fluorescence signal throughout the cell nucleus and cytoplasm. In contrast, p57GFP and p57NDelta 1 resulted in a distinct nuclear localization reminiscent of that observed previously with HVS-infected and ORF57-transfected cells (11). However, p57NDelta 2 and p57NDelta 3 resulted in fluorescence restricted to the cytoplasm. This indicated that the arginine-rich sequence contained within the amino terminus is required to direct the ORF57 protein to the nucleus (Fig. 5a).


View larger version (45K):
[in this window]
[in a new window]
 
Fig. 5.   The ORF 57 amino-terminal arginine-rich sequence functions as a NLS. To determine the subcellular localization of each ORF 57 amino-terminal deletion mutant, COS-7 cells remained untransfected (i) or were transfected with pGFP (ii), p57GFP (iii), p57NDelta 1 (iv), p57NDelta 2 (v), or p57NDelta 3 (vi). b, COS-7 cells remained untransfected (i) or were transfected with pEGFP-C1 (ii) or p57NLS (iii). After 24 h, the subcellular localization of GFP was observed using fluorescence microscopy. (c) Mutational analysis of the ORF 57 NLS. A range of site-directed mutations were constructed replacing the arginine or lysine residues of the ORF 57 NLS. d, COS-7 cells remained untransfected (i) or were transfected with p57GFP (ii), p57NLSM1 (iii), p57NLSM2 (iv), p57NLSM3 (v), p57NLSM4 (vi). After 24 h, the subcellular localization of GFP was observed using fluorescence microscopy.

To confirm that the arginine-rich sequence functions as a NLS, and enables nuclear import of a heterologous protein, the NLS was fused with GFP. COS-7 cell monolayers were transfected with either pEGFP-C1 or p57NLS-GFP, and the subcellular localization of GFP was observed. The results show that cells transfected with pEGFP-C1 displayed a fluorescence pattern throughout the cell, in both the nucleus and cytoplasm. However, the fluorescence pattern observed in p57NLS-GFP-transfected cells was confined to the nucleus and in particular the nucleolus (Fig. 5b).

Furthermore, to determine the importance of the arginine and lysine residues for ORF 57 nuclear localization, a range of site-directed mutations were constructed, p57NLSM1-4, incorporated the alteration of varying residues within the putative NLS to alanine (Fig. 5c). COS-7 cell monolayers were transfected with either p57GFP or p57NLSM1-4, and the subcellular localization of GFP was observed. The results show that cells transfected with p57GFP displayed a nuclear fluorescence pattern as observed previously. However, the fluorescence pattern observed in p57NLSM1-4-transfected cells was confined to the cytoplasm (Fig. 5d). This suggested that the ORF 57 amino-terminal arginine-rich sequence functions both as a NLS and possibly as a nucleolar localization signal, and the arginine and lysine residues are essential for this function.

ORF 57 Redistributes Importin alpha 1 and alpha 5 into the Nucleolus-- To determine the effect of ORF 57 on the subcellular localization of importin alpha 1 and alpha 5, indirect immunofluorescence was performed. Initially, the cDNAs of importin alpha 1 and importin alpha 5 were inserted into the eukaryotic expression vector, pcDNAGFP, allowing direct visualization of the importin alpha 1 and alpha 5 proteins. To confirm the molecular weight of importin alpha 1-GFP and alpha 5-GFP fusion proteins, Western blot analysis of transiently transfected cells was performed. Western blot analysis demonstrated that importin alpha 1-GFP and importin alpha 5-GFP encode the predicted 82- and 86-kDa proteins, respectively (data not shown).

To ascertain the subcellular localization of each importin alpha -GFP construct, transient transfections were performed and the fluorescence pattern was evaluated. Importin alpha 1-GFP resulted in a distinct perinuclear staining pattern, with faint fluorescence throughout the nucleus and cytoplasm (Fig. 6a). To determine if ORF 57 affected the subcellular localization of importin alpha 1 and alpha 5, dual immunofluorescence was performed using importin alpha 1-GFP and ORF57 co-transfected (Fig. 6a) or HVS-infected cells (data not shown). Cells only expressing importin alpha 1 resulted in the distinct perinuclear staining as previously described. In contrast, cells expressing ORF 57 showed a drastic redistribution of the importin alpha 1-GFP (Fig. 6a). This analysis showed that ORF 57 expression resulted in a strong nuclear fluorescence of importin alpha 1-GFP. Moreover, the fluorescence was concentrated in nuclear compartments, varying in number between 2 and 5 per cell, that resembled nucleoli (Fig. 6a). Essentially identical results were observed with importin alpha 5-GFP in the presence of the ORF 57 protein (data not shown).


View larger version (16K):
[in this window]
[in a new window]
 
Fig. 6.   The ORF 57 protein redistributes importin alpha  into the nucleolus. a, to determine whether ORF 57 affects the relocalization of importin alpha -GFP, COS-7 cells were transfected with palpha 1-GFP (i and ii) and palpha 1-GFP or p57 (iii and iv). ORF 57 was detected using an anti-ORF 57 polyclonal antiserum and an anti-rabbit Texas Red conjugate. Importin alpha  was directly visualized using fluorescence microscopy. b, to determine whether ORF 57/importin alpha  nuclear aggregations are concentrated in the nucleolus, untransfected (i) or palpha 1-GFP- and p57-transfected cells were labeled with a specific B23 monoclonal antibody and detected using an anti-rabbit Texas Red conjugate (v). Importin alpha  was directly visualized using fluorescence microscopy (vi).

To ascertain if the importin alpha  nuclear aggregations in the presence of ORF 57 are concentrated in the nucleolus, indirect dual immunofluorescence was performed. Importin alpha 1-GFP- and ORF 57-co-transfected cells were labeled with a monoclonal antibody, specific for a major nucleolar protein, B23. Results demonstrated that in the presence of ORF 57, importin alpha 1 was localized into nuclear aggregations, as described previously. Moreover, these distinct nuclear aggregations co-localized with B23 (Fig. 6b). This suggests that ORF 57 redistributes importin alpha 1 and alpha 5 into the nucleolus.

ORF 57 Reduces Nuclear Import of Other NLS-containing Proteins-- As demonstrated above, ORF 57 redistributes importin alpha 1 and alpha 5 into distinct nucleolar aggregations. To determine whether this redistribution affected the nuclear import of secondary NLS-containing proteins via the importin nuclear import pathway, transient transfections were performed. COS-7 cells were transfected with pSV40NLS-RFP, a transfer vector encoding a carboxyl-terminal fusion of the SV40 NLS and RFP, in the absence or presence of ORF57. Results demonstrate that that cells transfected with pSV40NLS-RFP displayed a fluorescence pattern confined to the nucleus. However, in contrast, cells expressing ORF 57 showed a reduced presence of SV40NLS-RFP in the nucleus and an increased amount in the cytoplasm (Fig. 7). This analysis suggests that ORF 57 may sequester importin alpha  in the nucleolus, thereby reducing nuclear import of secondary NLS-containing proteins via the importin pathway.


View larger version (18K):
[in this window]
[in a new window]
 
Fig. 7.   ORF 57 inhibits nuclear import of other NLS-containing proteins. COS-7 cells were transfected with pSV40NLS-RFP, in the absence or presence of p57GFP. After 24 h, the subcellular localization of SV40NLS-RFP (i and iii) and 57GFP (ii and iv) was observed using fluorescence microscopy.

ORF 57-Importin alpha  Interaction Is Required for Viral RNA Nuclear Export-- We have previously demonstrated that ORF 57 is a nucleocytoplasmic shuttle protein which mediates the nuclear export of viral mRNAs (6). To determine whether the interaction of ORF 57 and importin alpha  is required for viral RNA nuclear export, Northern blot analysis was performed. Total, nuclear, and cytoplasmic RNA were isolated separately from COS-7 cells transfected with pUCgB, a transfer vector containing the full-length coding region and promoter of the HVS late glycoprotein B gene, in the absence and presence of pRSVORF57 or p57NLSDelta 3. The RNA was then separated by electrophoresis, transferred to Hybond-N membranes, and hybridized with 32P-radiolabeled random-primed probe specific for the HVS gB and actin coding regions (Fig. 8). The results demonstrate, as described previously, ORF 57 is required for the efficient cytoplasmic accumulation of late viral transcripts (6). However, the deletion of the ORF 57 NLS results in the retention of late viral transcripts in the nucleus. This suggests that the ORF 57-importin alpha  interaction is required for ORF 57's nucleocytoplasmic shuttling ability and therefore the efficient nuclear export of late viral transcripts.


View larger version (55K):
[in this window]
[in a new window]
 
Fig. 8.   The ORF 57 NLS is required for the efficient nuclear export of viral mRNA. COS-7 cells transfected with pUCgB in the absence (lanes 1, 4, and 7) and presence of pRSVORF57 (lanes 2, 5, and 8) or p57NLSDelta 3 (lanes 3, 6, and 9). Total (lanes 1-3), nuclear (lanes 4-6), and cytoplasmic (lanes 7-9) RNA was then isolated and separated by electrophoresis on a 1% denaturing formaldehyde-agarose gel. The RNA was transferred to Hybond-N membranes and hybridized with a 32P-radiolabeled random-primed probes specific for the HVS gB and actin coding sequences.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

HVS ORF 57 is a member of the virus-encoded nucleocytoplasmic shuttle proteins involved in mediating the nuclear export of virus transcripts. (6). Other functionally homologous virus proteins include HIV-1 Rev, adenovirus E4orf6, HSV-1 ICP27, and influenza virus NEP (1-5). In this report, we have utilized the yeast two-hybrid system and co-immunoprecipitation analysis to demonstrate that ORF 57 interacts with importin alpha  isoforms 1 and 5. Importin alpha  functions as an adapter molecule binding NLS-containing molecules and the transport receptor, importin beta  (reviewed in Ref. 14). In contrast to importin beta , several isoforms of importin alpha  exist in higher eukaryotes. These can be grouped into three main subfamilies, which differ from one another in their amino acid comparison by ~50% (32, 33). The presence of multiple isoforms of importin alpha  suggest that each isoform may import specific substrates. There have been several experiments to support this theory. The nuclear import of the transcription factor Stat1 is mediated by importin alpha 5, but not importin alpha 1 (34). Moreover, Nadler et al. (35) utilized pull-down assays to demonstrate that importin alpha 1 and importin alpha 5 share distinct binding affinities for various NLSs. However, recent analysis has demonstrated that all importin alpha  isoforms could import most substrates with a similar efficiency (33). At present, we have not determined whether all the importin alpha  isoforms have distinct ORF 57 specificities.

Interestingly, a number of viral proteins have been shown to interact with importin alpha  and in turn exploit the importin-mediated pathway to enter the host cell nucleus. The influenza virus nucleoprotein (NP) has been shown to bind both importin alpha 1 and alpha 5 isoforms (36-38). Furthermore, the Epstein-Barr virus EBNA-1 protein, which is required for the replication and stable maintenance of the viral genome (reviewed in Ref. 39), has also been shown to interact with importin alpha 1 and alpha 5 isoforms (40, 41). Moreover, nuclear import of the human papillomavirus (strain 11) L1 major capsid has been shown to be mediated by the importin pathway via importin alpha 5 binding (42). More recently, HIV-1 Rev has been shown to utilize the importin-mediated pathway but independently of importin alpha  (43, 44). The HIV-1 Rev arginine-rich NLS has been demonstrated to interact directly with importin beta  which mediates the import of Rev, using in vitro import assays (43, 44).

Further analysis of the ORF 57 (RRPSRPFRK), EBNA-1, and NP NLSs show very limited, if any, homology. The EBNA-1 NLS, KRPRSPSS, has been shown to be required for both importin alpha 1 and alpha 5 binding. Moreover, additional upstream and downstream sequences are required for importin alpha 1 binding (45). In contrast, the influenza A NP contains two overlapping non-conventional NLSs (38). Mutational analysis by alanine scanning identified differing motifs required for importin alpha 1 and alpha 5 binding: SXGTKRSYXXM for importin alpha 5 and TKRSXXXM for importin alpha 1 binding (38). Although data presented in this report suggest that ORF 57 utilizes the same NLS for both importin alpha 1 and alpha 5 binding, it cannot be excluded that the NLS contains overlapping motifs that specify importin alpha  isoform binding.

Insights into the binding of NLS-containing proteins to importin alpha  have been revealed by examination of the crystal structure of yeast and mammalian importin alpha  molecules (46, 47). Sequence analysis has revealed that importin alpha  is composed of three distinct domains (20, 48): a basic amino-terminal importin beta -binding domain; a large central domain composed of 8-10 arm repeats; and an acidic carboxyl terminus, which mediates an interaction with the nuclear export factor, CAS (24-26). Co-crystallization studies of importin alpha  and a monopartite NLS has identified two possible binding sites (46, 47). The major site lies at the amino-terminal end of the receptor between the first and fourth arm repeats, and the minor site is located at the carboxyl terminus between arm repeats 4 and 8. At both sites, the NLS binds in an extended antiparallel conformation, via tryptophan and asparagine residues (46, 47). Moreover, the bipartite nucleoplasmin NLS simultaneously binds to both major and minor sites (46, 47). From these studies we infer that ORF 57 contains a monopartite NLS, which specifically binds to the minor repeats at the carboxyl terminus between the fourth and eight arm repeats. Similar observations have demonstrated that this is the minimal region required for the interaction of importin alpha 1 with EBNA1-NLS (40) and importin alpha 2 with LEF-1 NLS (49).

Interestingly, upon nuclear import of the ORF 57-importin alpha  complex, we have demonstrated that this complex is directed to the nucleolus. Results herein suggest that the ORF 57 amino-terminal arginine-rich domain mediates both nuclear and nucleolar localization. Similar nucleolar targeting has been observed with HIV-1 (50-52). However, no functional role has yet been attributed to this localization and it is the matter of some debate. It has recently been reported that Rev induces the redistribution of the nucleoporins Nup98 and Nup214, in addition to the nuclear export factor CRM-1, into the nucleolus (53). These findings suggest that assembly of the Rev-nuclear export complex occurs in the nucleolus. However, data generated utilizing an HIV-1 nucleolar-localized ribozyme suggest that HIV-1 transcripts undergo nucleolar trafficking (54). This has led to speculation that a ribonucleoprotein particle containing HIV-1 RNA, regulatory proteins, and cellular factors, involved in the post-transcriptional modification or export and translation of HIV-1 transcripts, occurs in the nucleolus. Whether the nucleolus plays similar roles in ORF 57 functioning is unknown and warrants further investigation.

In conclusion, our data demonstrate that the multifunctional ORF 57 nucleocytoplasmic shuttle protein interacts with importin alpha  isoforms 1 and 5. The binding of ORF 57 to importin alpha  is mediated by the hydrophobic, internal, importin alpha  armadillo repeats. An ORF 57 amino-terminal arginine-rich sequence, which functions as an NLS, was also required for this interaction. Furthermore, the ORF 57 protein is responsible for the redistribution of importin alpha  into the nucleoli. Moreover, preliminary experiments suggest that this redistribution reduce nuclear import of secondary NLS-containing protein via the importin-mediated nuclear import pathway. These results suggest that ORF 57 is a nucleocytoplasmic shuttle protein, which re-enters the nucleus via the importin beta -mediated pathway and this interaction is necessary for the efficient nuclear export of viral RNA transcripts. Future studies will be directed to determine which cellular pathway ORF 57 utilizes to exit the nucleus and the functional significance of the nucleolus in the functioning of this important herpesvirus regulatory protein.

    ACKNOWLEDGEMENTS

We are very grateful to Matthias Köhler, Dirk Görlich, Peter Palese, and David Matthews for providing antibody reagents and expression constructs used in this work. We thank Alex Markham for critical reading of this manuscript.

    FOOTNOTES

* This work was supported in part by grants from the Medical Research Council (MRC) and Yorkshire Cancer Research.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger Recipient of a MRC studentship.

§ Recipient of a MRC fellowship. To whom correspondence should be addressed. Tel.: 44-113-2066328; Fax: 44-113-2444475; E-mail: a.whitehouse@leeds.ac.uk.

Published, JBC Papers in Press, March 16, 2001, DOI 10.1074/jbc.M009513200

    ABBREVIATIONS

The abbreviations used are: HIV-1, human immunodeficiency virus type 1; HSV, herpes simplex virus; HVS, H. saimiri; PCR, polymerase chain reaction; bp, base pair(s); ORF, open reading frame; NLS, nuclear localization sequence; GFP, green fluorescent protein; GST, glutathione S-transferase; PAGE, polyacrylamide gel electrophoresis; PBS, phosphate-buffered saline; DBD, DNA-binding domain; AD, activation domain; NP, nucleoprotein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Kalland, K. H., Szilvay, A. M., Brokstad, K. A., Saetrevik, W., and Haukenes, G. (1994) Mol. Cell. Biol. 118, 7436-7444
2. Meyer, B. E., and Malim, M. H. (1994) Genes Dev. 8, 1538-1547[Abstract]
3. Sandri-Goldin, R. M. (1998) Genes Dev. 12, 868-879[Abstract/Free Full Text]
4. O'Neill, R. E., Talon, J., and Palase, P. (1998) EMBO J. 17, 288-296[Abstract/Free Full Text]
5. Dobblestein, M., Roth, J., Kimberly, W. T., Levine, A. J., and Shenk, T. (1997) EMBO J. 16, 4276-4282[Abstract/Free Full Text]
6. Goodwin, D. J., Hall, K. T., Stevenson, A. J., Markham, A. F., and Whitehouse, A. (1999) J. Virol. 73, 10519-10524[Abstract/Free Full Text]
7. Albrecht, J. C., Nicholas, J., Biller, D., Cameron, K. R., Biesinger, B., Newman, C., Wittman, S., Craxton, M. A., Coleman, H., Fleckenstein, B., and Honess, R. W. (1992) J. Virol. 66, 5047-5058[Abstract]
8. Chang, Y., Cesarman, E., Pessin, M. S., Lee, F., Culpepper, J., Knowles, D. M., and Moore, P. S. (1994) Science 265, 1865-1869
9. Nicholas, J., Coles, L. S., Newman, C., and Honess, R. W. (1991) J. Virol. 65, 2457-2466[Medline] [Order article via Infotrieve]
10. Whitehouse, A., Carr, I. M., Griffiths, J. C., and Meredith, D. M. (1997) J. Virol. 71, 2550-2554[Abstract]
11. Whitehouse, A., Cooper, M., and Meredith, D. M. (1998) J. Virol. 72, 857-861[Abstract/Free Full Text]
12. Whitehouse, A., Cooper, M., Hall, K. T., and Meredith, D. M. (1998) J. Virol. 72, 1967-1973[Abstract/Free Full Text]
13. Cooper, M., Goodwin, D. J., Hall, K. T., Stevenson, A. J., Meredith, D. M., Markham, A. F., and Whitehouse, A. (1999) J. Gen. Virol. 80, 1311-1316[Abstract]
14. Görlich, D., and Kutay, U. (1999) Annu. Rev. Cell Dev. Biol. 15, 607-660[CrossRef][Medline] [Order article via Infotrieve]
15. Fornerod, M., Ohno, M., Yoshida, M., and Mattaj, I. W. (1997) Cell 90, 1051-1060[Medline] [Order article via Infotrieve]
16. Ossareh-Nazari, B., Bachelerie, F., and Dargemont, C. (1997) Science 278, 767-775[CrossRef]
17. Soliman, T. M., and Silverstein, S. J. (2000) J. Virol. 74, 2814-2825[Abstract/Free Full Text]
18. Farjot, G., Buisson, M., Dodon, M. D., Gazzolo, L., Sergeant, A., and Mikaelian, I. (2000) J. Virol. 74, 6068-6076[Abstract/Free Full Text]
19. Weis, K., Mattaj, I. W., and Lamond, A. I. (1995) Science 268, 1049-1053[Medline] [Order article via Infotrieve]
20. Görlich, D., Henklien, P., Laskey, R. A., and Hartmann, E. (1996) EMBO J. 15, 1810-1817[Abstract]
21. Weis, K., Ryder, U., and Lamond, A. I. (1996) EMBO J. 15, 1818-1825[Abstract]
22. Rexach, M., and Blobel, G. (1995) Cell 83, 683-692[Medline] [Order article via Infotrieve]
23. Görlich, D., Panté, N., Kutay, U., Aebi, U., and Bischoff, F. F. (1996) EMBO J. 15, 5584-5594[Abstract]
24. Kutay, U., Bischoff, F. R., Kostka, S., Kraft, R., and Görlich, D. (1997) Cell 90, 1061-1071[Medline] [Order article via Infotrieve]
25. Solsbacher, J., Maurer, P., Bischoff, F. R., and Schlenstedt, G. (1998) Mol. Cell. Biol. 18, 6805-6815[Abstract/Free Full Text]
26. Hood, J. K., and Silver, R. A. (1998) J. Biol. Chem. 273, 142-146
27. Coutavas, E., Ren, M., Oppenheim, J. D., D'Eustachio, P., and Rush, M. G. (1993) Nature 366, 585-587[CrossRef][Medline] [Order article via Infotrieve]
28. Bischoff, F. R., Krebber, H., Smirnova, E., Dong, W. H., and Ponstingl, H. (1995) EMBO J. 14, 705-715[Abstract]
29. Schlenstedt, G., Wong, D. H., Koepp, D. M., and Silver, P. A. (1995) EMBO J. 14, 5367-5378[Abstract]
30. Chien, C. T., Bartel, P. L., Sternglanz, R., and Fields, S. (1991) Proc. Natl. Acad. Sci. U. S. A. 88, 9578-82[Abstract]
31. Goodwin, D. J., Hall, K. T., Giles, M. S., Calderwood, M. A., Markham, A. F., and Whitehouse, A. (2000) J. Gen. Virol. 81, 2253-2265[Abstract/Free Full Text]
32. Köhler, M., Ansieau, S., Prehn, S., Leutz, H., Haller, H., and Hartmann, E. (1999) FEBS Lett. 417, 104-108[CrossRef]
33. Köhler, M., Speck, C., Christiansen, M., Bischoff, F. R., Prehn, S., Haller, H., Görlich, D., and Hartmann, E. (1999) Mol. Cell. Biol. 19, 7782-7791[Abstract/Free Full Text]
34. Sekimoto, T., Imamoto, N., Nakajima, K., Hirano, T., and Yoneda, Y. (1997) EMBO J. 16, 7067-7077[Abstract/Free Full Text]
35. Nadler, S. G., Tritschler, D., Haffar, O. K., Blake, J., Bruce, A. G., and Cleaveland, J. S. (1997) J. Biol. Chem. 272, 4310-4315[Abstract/Free Full Text]
36. O'Neill, R. E., and Palase, P. (1998) Virology 206, 116-125[CrossRef]
37. O'Neill, R. E., Jaskunas, R., Blobel, G., Palase, P., and Moroianu, J. (1995) J. Biol. Chem. 270, 22701-22704[Abstract/Free Full Text]
38. Wang, P., Palese, P., and O'Neill, R. E. (1997) J. Virol. 71, 1850-1856[Abstract]
39. Kieff, E. (1996) in Fields Virology (Fields, B. N. , Knipe, D. M. , Howley, P. M. , Chanock, R. M. , Melnick, J. L. , Monath, T. P. , Roizman, B. , and Straus, S. E., eds), 3rd Ed. , pp. 2343-2396, Lippincott-Raven Publishers, Philadelphia
40. Fischer, N., Kremmer, E., Lautscham, G., Mueller-Lantzsch, N., and Grässer, F. A. (1997) J. Biol. Chem. 272, 3999-4005[Abstract/Free Full Text]
41. Ito, S., Ikeda, M., Kato, N., Matsumato, A., Ishikawa, Y., Kumakubo, S., and Yanagi, K. (2000) Virology 266, 110-119[CrossRef][Medline] [Order article via Infotrieve]
42. Merle, E., Rose, R. C., LeRoux, L., and Moroianu, J. (1999) J. Cell. Biochem. 15, 628-637[CrossRef]
43. Henderson, B. R., and Percipalle, P. (1997) J. Mol. Biol. 274, 693-707[CrossRef][Medline] [Order article via Infotrieve]
44. Truant, R., and Cullen, B. R. (1999) Mol. Cell. Biol. 19, 1210-1217[Abstract/Free Full Text]
45. Kim, A. L., Maher, M., Hayman, J. B., Ozer, J., Zerby, D., Yates, J. L., and Lieberman, P. M. (1997) Virology 239, 340-351[CrossRef][Medline] [Order article via Infotrieve]
46. Conti, E., Uy, M., Leighton, L., Blobel, G., and Kuriyan, J. (1998) Cell 94, 193-204[Medline] [Order article via Infotrieve]
47. Fontes, M. R. M., Trazel, T., and Kobe, B. (2000) J. Mol. Biol. 297, 1183-1194[CrossRef][Medline] [Order article via Infotrieve]
48. Peifer, M., Berg, S., and Reynolds, A. B. (1996) Cell 76, 789-791
49. Herold, A., Truant, R., Wiegand, H., and Cullen, B. R. (1998) J. Cell Biol. 143, 309-318[Abstract/Free Full Text]
50. Cochrane, A. W., Perkins, A., and Rosen, C. A. (1990) J. Virol. 64, 881-885[Medline] [Order article via Infotrieve]
51. Venkatesh, L. K., Mohammed, S., and Chinnadurai, G. (1990) Virology 176, 39-47[Medline] [Order article via Infotrieve]
52. Hammerschmid, M., Palmeri, D., Ruhl, M., Jaksche, H., Wiechselbraun, I., Bohnlein, E., Malim, M. H., and Hauber, J. (1994) J. Virol. 68, 7329-7335[Abstract]
53. Zolotukhin, A. S., and Felber, B. K. (1999) J. Virol. 73, 120-127[Abstract/Free Full Text]
54. Michienzi, A., Cagnon, L., Bahner, I., and Rossi, J. J. (2000) Proc. Natl. Acad. Sci. U. S. A. 97, 8955-8960[Abstract/Free Full Text]


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.